Skip to main content
Clinical Trials/NL-OMON55609
NL-OMON55609
Recruiting
Phase 2

Anatomical mapping and assessment of tissue perfusion using indocyanine green near-infrared fluorescence in patients with peripheral arterial disease. - ICG-NIRF in peripheral vascular disease

eids Universitair Medisch Centrum0 sites110 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
claudication
Sponsor
eids Universitair Medisch Centrum
Enrollment
110
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- 18 years or older
  • \- patients with peripheral vascular disease catagorized wit at least fontaine
  • 2A classification
  • \- Abscence of any psychological, familial, sociological or geographical
  • condition potentially hampering
  • compliance with the study protocol and follow\-up schedule; those conditions
  • should be discussed with the patient before registration in the trial.
  • \- Before patient registration, written consent must be given according to
  • ICH/GCP, national and local
  • regulations.

Exclusion Criteria

  • \- hisory of allergy to iodine, shellfish or ICG
  • \- patients with hyperthyroidism
  • \- pregnant or lactating woman
  • \- any condition that in the opinion of the investigator could potentially
  • jeopardize the health status of the patient.
  • \- patients with severe liver failure

Outcomes

Primary Outcomes

Not specified

Similar Trials